Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbiota composition describes the identity, abundance, and diversity of microbes (including bacteria, archaea, viruses, and fungi) present at a given anatomical or environmental site. Its assessment is central to understanding host-microbe interactions, metabolic and immune regulation, and disease mechanisms. Changes in microbiota composition—termed dysbiosis—have been linked to numerous diseases, and therapies now exist to manipulate these communities via antibiotics, probiotics, prebiotics, and interventions such as fecal microbiota transplantation. However, microbiota composition is not itself a molecular target, but rather a community-level metric, used to design and evaluate therapeutic approaches, identify biomarkers, and monitor efficacy and safety in translational research[1][2][3][4][5][6].
The mechanism of action for interventions targeting microbiota composition involves the alteration of microbial abundance and diversity, selective elimination of pathogenic taxa, addition of beneficial microorganisms, and modulation of microbial metabolic activities.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbiota composition.